Top-Thema

17:13 Uhr +0,94%
Gasekonzerne Linde und Praxair planen wieder Zusammen­schluss

CellaVision AB: Presents the third quarter 2016 on October 27 at 11:00 CET

Montag, 17.10.2016 08:25

CellaVision presents the third quarter 2016 on October 27 at 11:00 CET

The information was submitted to the public on October 17, 2016 at 8:20 CET

CellaVision will publish the interim report for the third quarter on October 27, 2016 at 08:20 CET. The report will be available at www.cellavision.com

In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Zlatko Rihter, CEO, will present and comment the report.

The presentation will be in English via a conference call or audio webcast:

https://wonderland.videosync.fi/cellavision-q3-report-2016

Phone number for the conference:

SE: +46 856642508

UK: +44 2030089808

US: +1 8558315946

No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the mother company in Lund and by the market support organizations in the US, Canada, China, Japan, Dubai, Korea, Australia and France. In 2015 sales were SEK 239 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more at www.cellavision.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CellaVision AB via Globenewswire